Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Shanghai ChemPartner’s Animal Facility Awarded AAALAC Accreditation

By Pharmaceutical Processing | March 3, 2010

Shanghai ChemPartner, a China-based contract research organization and a wholly-owned subsidiary of ShangPharma, has announced that its animal facility has received accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) International.

AAALAC International is a private, non-profit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. As a result of an extensive on-site evaluation, AAALAC determined that Shanghai ChemPartner’s animal facility is committed to the highest level of animal care and research practices. AAALAC noted the following in its official approval letter: “The Shanghai ChemPartner management and staff are commended for providing sound facilities and programs for the care and use of laboratory animals. Especially noteworthy were the strong administrative commitment to the program, as evidenced by the financial support for the three well maintained, state-of-the-art animal facilities and equipment, as well as the highly capable and qualified animal resources staff; the active, conscientious, capable and very knowledgeable Institutional Animal Care and Use Committee (IACUC); the knowledgeable and experienced animal care and use staff; the dedication of a team who worked extremely well together to ensure responsible and appropriate animal care and use; the excellent documentation (Standard Operating Procedures and guidelines) and records, with attention to detail and completeness; and the good animal health. Therefore, FULL ACCREDITATION is awarded.”

“The AAALAC accreditation comes as a result of our efforts in expanding service capabilities from chemistry to preclinical drug development including in vivo pharmacology, drug metabolism and pharmacokinetics (DMPK) and toxicology,” commented Michael Hui, founder and CEO of ChemPartner. “We are pleased to receive such high praise from the leading independent world body on the care and use of laboratory animals. We are confident of being an industry leader with the endorsement of AAALAC.”

 

Related Articles Read More >

FDA logo
FDA prevented 317 drug shortages in 2021
Pfizer-BioNTech vaccine vial
Pfizer, BioNTech moving forward on seeking COVID-19 vaccine EUA for youngest children
FDA logo
FDA curtails use of Janssen COVID-19 vaccine over blood clotting concerns
FDA logo
FDA sends warning letters to CBD and delta-8 THC product vendors

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards